ClinicalThought
View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Expert commentary discussing the early identification and prognosis of NAFLD, from Clinical Care Options (CCO)
Manal F. Abdelmalek, MD, MPH
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: March 16, 2021
Expired:
March 15, 2022
Interactive video from Dr. Manal Abdelmale and CCO: Who is at risk and who should be evaluated for progression to advanced fibrosis in NASH?
Manal F. Abdelmalek, MD, MPH
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: March 15, 2021
Expired:
March 14, 2022
Unlocked slides from Manal Abdelmalek, MD, MPH, and CCO: Who is at risk and who should be evaluated for progression to advanced fibrosis in NASH?
Manal F. Abdelmalek, MD, MPH
Released: March 15, 2021
Unlocked slides from Brent Tetri, MD, and CCO: impact of NASH and the interplay with diabetes, obesity, and cardiovascular disease
Brent A. Neuschwander-Tetri, MD
Released: February 3, 2021
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
